Recently, the National Pharmaceutical Project successfully won the bid for two key projects of Jiangsu Hengrui Pharmaceutical Co., Ltd.-Shandong Ruiyuan Pharmaceutical Co., Ltd. raw material drug industrialization base project and Shandong Shengdi production base preparation plant design project.

01 shandong Ruiyuan Pharmaceutical Co., Ltd. Raw Material Drug Industrialization Base Project

The project is located in Lianyungang Economic and Technological Development Zone, covering an area of about282 mu, with a total construction area of about14 wanfang. The project adopts advanced concepts such as logistics automation, equipment modularization, function intensification, and production flexibility to build a modern API industry base covering core facilities such as production workshops, intelligent logistics, quality inspection research and development, power centers, and sewage treatment stations. It will help Hengrui Medicine vertically integrate the industrial chain layout, strengthen the innovative drug ecosystem, and further enhance international competitiveness.

02 shandong Shengdi Production Base Preparation Plant Design Project

The project is located in Jinan High-tech Zone, covering an area of about198 acres. The project adopts "automation information the "intelligent" trinity design realizes the digital connection of the whole chain from production to management, and is committed to building a green and low-carbon smart park integrating R & D and production, marking an important step in the transformation of China's pharmaceutical industry to intelligence and sustainability.

In the future, the National Pharmaceutical Project will promote the landing of the project with higher standards, better quality and stronger execution, build an intelligent, green and international benchmark API base for Hengrui Medicine, and continue to empower the high-quality development of China's pharmaceutical industry.

(Wuhan Company Contribution)